Misoprostol 0.024 mg/g Topical Cream is a semisolid preparation dispensed in a pump mechanism, designed for convenient and controlled application on the skin. This formulation is used for the localized treatment or absorption of active ingredients to manage conditions such as cervical ripening, induction of labor, and prevention of gastric ulcers. The topical application ensures targeted delivery, enhancing therapeutic outcomes while minimizing systemic exposure.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Misoprostol 0.024 mg/g Topical Cream is a compounded semisolid preparation designed for application on the skin. Dispensed in a pump mechanism, this formulation allows for convenient and controlled dosing, ensuring that patients receive a consistent amount of the active ingredient with each use. Misoprostol is a synthetic prostaglandin E1 analog known for its various pharmacological effects, including vasodilation and modulation of inflammatory responses.
When applied topically, Misoprostol may aid in enhancing blood flow to the localized area, which can be beneficial in conditions where improved circulation is desired. The topical route targets the affected area directly, potentially reducing systemic side effects associated with oral administration. The cream's formulation ensures optimal absorption of Misoprostol through the skin, facilitating its therapeutic action at the site of application.
For patients, this means a tailored treatment option that addresses specific needs not met by standard medications. The controlled dispensing mechanism reduces the likelihood of dosing errors, promoting safer use. Patients should apply the cream as directed by their healthcare provider, typically to clean, unbroken skin, and should avoid contact with mucous membranes unless otherwise instructed.
Healthcare providers may consider prescribing Misoprostol Topical Cream for off-label uses supported by clinical experience or emerging research. The compound's ability to promote vasodilation and influence local inflammatory processes can make it a valuable tool in personalized medicine. Prescribers should thoroughly evaluate the patient's condition and medical history to determine the suitability of this therapy.
It is important to note that Misoprostol can cause uterine contractions and is contraindicated in pregnant women due to the risk of miscarriage or premature labor. Women of childbearing potential should use effective contraception during treatment and consult their healthcare provider immediately if pregnancy is suspected.
Misoprostol 0.024 mg/g topical cream is a formulation designed for localized application on the skin, utilizing a pump mechanism for precise dosing. While primarily used for its effects on the skin, it is important to consider potential drug interactions, especially for patients who may be using other medications concurrently. Misoprostol is a synthetic prostaglandin E1 analog, and its systemic absorption, although minimal in topical form, can still lead to interactions with other drugs.
Patients using anticoagulants, such as warfarin, should be cautious, as prostaglandins can potentially enhance the effects of these medications, increasing the risk of bleeding. Although the systemic absorption of misoprostol from topical application is low, it is advisable to monitor for any signs of increased bleeding or bruising. Additionally, patients on antihypertensive medications should be aware that prostaglandins can influence blood pressure regulation. While significant interactions are unlikely with topical use, it is prudent to monitor blood pressure regularly to ensure stability.
For patients taking nonsteroidal anti-inflammatory drugs (NSAIDs), it is important to note that misoprostol is often used to mitigate the gastrointestinal side effects of NSAIDs when taken orally. However, when applied topically, the interaction is less relevant, but patients should still be aware of the potential for systemic effects if using high doses or over large areas of the skin. Furthermore, patients on diuretics or other medications affecting renal function should be cautious, as prostaglandins can influence renal blood flow. Although the risk is minimal with topical application, it is advisable to monitor renal function periodically.
Prescribers should consider the patient's overall medication regimen and health status when recommending misoprostol topical cream. It is essential to evaluate the potential for interactions with other medications the patient may be taking, especially those with narrow therapeutic indices or those that are highly protein-bound. Additionally, patients should be advised to report any unusual symptoms or side effects promptly, as these may indicate an interaction or adverse effect.
In summary, while the risk of significant drug interactions with misoprostol 0.024 mg/g topical cream is low due to its localized application and minimal systemic absorption, it is important to remain vigilant. Patients and prescribers should be aware of the potential interactions with anticoagulants, antihypertensives, NSAIDs, and medications affecting renal function. Regular monitoring and open communication between patients and healthcare providers are key to ensuring safe and appropriate use of this formulation. If you have any questions or concerns about drug interactions or the use of this formulation, please reach out to us for further assistance.
Misoprostol 0.024 mg/g topical cream is a specialized formulation designed to deliver the active ingredient, misoprostol, directly to the skin for localized treatment. Misoprostol is a synthetic prostaglandin E1 analog, which means it mimics the action of naturally occurring prostaglandins in the body. Prostaglandins are lipid compounds that have diverse hormone-like effects, including the modulation of inflammation, protection of the gastric lining, and regulation of smooth muscle contraction. In this topical formulation, misoprostol is utilized for its ability to enhance blood flow, promote healing, and potentially modulate inflammatory responses in the skin.
The semisolid preparation of misoprostol is dispensed through a pump mechanism, ensuring a consistent and controlled dose with each application. This design not only enhances the ease of use for patients but also ensures that the medication is applied evenly across the affected area, maximizing its therapeutic effects. The cream base is formulated to facilitate the absorption of misoprostol through the skin barrier, allowing the active ingredient to reach the target tissues effectively. This localized delivery minimizes systemic exposure, reducing the risk of side effects commonly associated with oral administration of prostaglandins.
Misoprostol topical cream is primarily used for conditions where enhanced blood flow and anti-inflammatory effects are beneficial. By increasing local blood circulation, misoprostol can aid in the delivery of oxygen and nutrients to the affected area, promoting tissue repair and regeneration. Additionally, its anti-inflammatory properties can help reduce swelling, redness, and discomfort associated with various dermatological conditions. The precise mechanism by which misoprostol exerts these effects involves the activation of specific prostaglandin receptors in the skin, leading to a cascade of cellular responses that facilitate healing and reduce inflammation.
For prescribers, it is important to consider the specific needs of the patient and the condition being treated when recommending misoprostol topical cream. The formulation's ability to provide targeted therapy with minimal systemic involvement makes it an attractive option for patients who may not tolerate oral medications well or who require localized treatment. Patients should be instructed on the proper use of the pump mechanism to ensure accurate dosing and should be advised to apply the cream to clean, dry skin to optimize absorption.
If you have any questions about this formulation or its use, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to make informed decisions about your treatment options.
Misoprostol 0.024 mg/g Topical Cream is used for localized treatment or absorption of active ingredients through the skin. It is often prescribed for specific medical conditions as determined by a healthcare provider.
Apply the cream as directed by your healthcare provider. Typically, it is dispensed in a pump mechanism for convenient and controlled application on the skin. Ensure the area is clean and dry before application.
Misoprostol 0.024 mg/g Topical Cream should be used only on the areas specified by your healthcare provider. Avoid applying it to broken or irritated skin unless directed otherwise.
The frequency of application will be determined by your healthcare provider based on your specific condition and needs. Follow their instructions carefully.
Some users may experience mild skin irritation or redness at the application site. If you notice severe reactions or other unusual symptoms, contact your healthcare provider immediately.
Consult your healthcare provider before using other skin products in conjunction with Misoprostol 0.024 mg/g Topical Cream to avoid potential interactions or reduced effectiveness.
Store the cream at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
If you miss a dose, apply it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.
Misoprostol is known to cause uterine contractions and should not be used during pregnancy unless specifically prescribed by a healthcare provider. Discuss any concerns with your doctor.
The use of Misoprostol 0.024 mg/g Topical Cream in children should be determined by a healthcare provider. It is important to follow their guidance and recommendations.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)